{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T22:00:00Z","timestamp":1766786400863,"version":"3.48.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"DOI":"10.7759\/cureus.100145","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T21:58:22Z","timestamp":1766786302000},"source":"Crossref","is-referenced-by-count":0,"title":["Budd-Chiari Syndrome Secondary to Essential Thrombocythaemia Complicated by Acquired Von Willebrand Disease and Mimicking Hepatic Malignancy: A Case Report"],"prefix":"10.7759","author":[{"given":"Faryal","family":"Rahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen","family":"Yi Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Siy-yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenaz","family":"Joomye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Budd-Chiari syndrome: current perspectives and controversies","volume":"20","author":"Liu L","year":"2016","unstructured":"Liu L, Qi XS, Zhao Y, Chen H, Meng XC, Han GH. Budd-Chiari syndrome: current perspectives and controversies. Eur Rev Med Pharmacol Sci. 2016, 20:3273-81.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref2","article-title":"Budd-Chiari syndrome","author":"Hitawala AA","year":"2025","unstructured":"Hitawala AA, Goosenberg E. Budd-Chiari syndrome. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref3","unstructured":"Medscape. Budd-Chiari syndrome. (2024). https.\/\/emedicine.medscape.com\/article\/184430-overview?form=fpf."},{"key":"ref4","unstructured":"Budd-Chiari syndrome. (2024). Accessed. November 19, 2025: https:\/\/patient.info\/doctor\/gastroenterology\/budd-chiari-syndrome-pro."},{"key":"ref5","unstructured":"Budd-Chiari Syndrome. (2023). Accessed. November 19, 2025: https:\/\/liverfoundation.org\/liver-diseases\/pediatric-liver-information-center\/pediatric-liver-disease\/budd-chiari-syn...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-68239-4_90","article-title":"Budd-Chiari syndrome III \u2014 Nodules mimicking malignancy","author":"Hussain S","year":"2007","unstructured":"Hussain S. Budd-Chiari syndrome III \u2014 Nodules mimicking malignancy. Liver MRI. Springer, Berlin, Germany; 2007. 192-3. 10.1007\/978-3-540-68239-4_90"},{"key":"ref7","article-title":"Essential thrombocytosis","author":"Kaur A","year":"2025","unstructured":"Kaur A, Gohari P. Essential thrombocytosis. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref8","unstructured":"Blood Cancer UK. What is essential thrombocythaemia (ET)?. (2025). Accessed. November 19, 2025: https:\/\/bloodcancer.org.uk\/understanding-blood-cancer\/essential-thrombocythaemia-et\/et-explained\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Rumi E","year":"2014","unstructured":"Rumi E, Pietra D, Ferretti V, et al.. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2014, 123:1544-51. 10.1182\/blood-2013-11-539098","journal-title":"Blood"},{"key":"ref10","unstructured":"DynaMed. Acquired von Willebrand syndrome. (2025). Accessed. November 19, 2025: https:\/\/www.dynamed.com\/condition\/acquired-von-willebrand-syndrome."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071746","article-title":"Essential thrombocythemia and acquired von Willebrand syndrome: the shadowlands between thrombosis and bleeding","volume":"12","author":"Awada H","year":"2020","unstructured":"Awada H, Voso MT, Guglielmelli P, Gurnari C. Essential thrombocythemia and acquired von Willebrand syndrome: the shadowlands between thrombosis and bleeding. Cancers (Basel). 2020, 12:1746. 10.3390\/cancers12071746","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000507883","article-title":"A case of acquired von Willebrand disease secondary to myeloproliferative neoplasm","volume":"13","author":"Sasi S","year":"2020","unstructured":"Sasi S, Yassin MA, Fadul AM. A case of acquired von Willebrand disease secondary to myeloproliferative neoplasm. Case Rep Oncol. 2020, 13:733-7. 10.1159\/000507883","journal-title":"Case Rep Oncol"},{"key":"ref13","article-title":"Myeloproliferative neoplasms","author":"Thapa B","year":"2025","unstructured":"Thapa B, Fazal S, Parsi M, Rogers HJ. Myeloproliferative neoplasms. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.278499","article-title":"The possible role of mutated endothelial cells in myeloproliferative neoplasms","volume":"106","author":"Farina M","year":"2021","unstructured":"Farina M, Russo D, Hoffman R. The possible role of mutated endothelial cells in myeloproliferative neoplasms. Haematologica. 2021, 106:2813-23. 10.3324\/haematol.2021.278499","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4724","article-title":"State of the art, current perspectives, and controversies of Budd-Chiari syndrome: a review","volume":"14","author":"Gavriilidis P","year":"2022","unstructured":"Gavriilidis P, Marangoni G, Ahmad J, Azoulay D. State of the art, current perspectives, and controversies of Budd-Chiari syndrome: a review. J Clin Med Res. 2022, 14:147-57. 10.14740\/jocmr4724","journal-title":"J Clin Med Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S425535","article-title":"Budd-Chiari syndrome as an initial presentation of systemic lupus erythematosus associated with antiphospholipid syndrome: a case report with review of the literature","volume":"15","author":"Solela G","year":"2023","unstructured":"Solela G, Daba M. Budd-Chiari syndrome as an initial presentation of systemic lupus erythematosus associated with antiphospholipid syndrome: a case report with review of the literature. Open Access Rheumatol. 2023, 15:139-43. 10.2147\/OARRR.S425535","journal-title":"Open Access Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12554","article-title":"Budd-Chiari syndrome: a case report of a rare presentation of COVID-19","volume":"13","author":"Sh Hassan AA","year":"2021","unstructured":"Sh Hassan AA, Alsaleh ME, Alsaleh ME, et al.. Budd-Chiari syndrome: a case report of a rare presentation of COVID-19. Cureus. 2021, 13:e12554. 10.7759\/cureus.12554","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvir.2025.101087","article-title":"Interventional radiology management of Budd-Chiari syndrome: current concepts","volume":"28","author":"Sanogo ML","year":"2025","unstructured":"Sanogo ML, Chavan M, Kapoor BS. Interventional radiology management of Budd-Chiari syndrome: current concepts. Tech Vasc Interv Radiol. 2025, 28:101087. 10.1016\/j.tvir.2025.101087","journal-title":"Tech Vasc Interv Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13180","article-title":"Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome","volume":"37","author":"Tripathi D","year":"2017","unstructured":"Tripathi D, Sunderraj L, Vemala V, et al.. Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome. Liver Int. 2017, 37:111-20. 10.1111\/liv.13180","journal-title":"Liver Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/AJIR.AJIR_11_18","article-title":"Outcome of transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome: long-term outcomes of 118 patients; a single-center experience","volume":"2","author":"Shaker M","year":"2018","unstructured":"Shaker M, Sakr M, Dabbous H, et al.. Outcome of transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome: long-term outcomes of 118 patients; a single-center experience. Arab J Intervent Radiol. 2018, 2:75-81. 10.4103\/AJIR.AJIR_11_18","journal-title":"Arab J Intervent Radiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013777","article-title":"Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis","volume":"8","author":"Venkat RK","year":"2024","unstructured":"Venkat RK, Redd RA, Harris AC, et al.. Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis. Blood Adv. 2024, 8:6043-54. 10.1182\/bloodadvances.2024013777","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442849-budd-chiari-syndrome-secondary-to-essential-thrombocythaemia-complicated-by-acquired-von-willebrand-disease-and-mimicking-hepatic-malignancy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T21:58:24Z","timestamp":1766786304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442849-budd-chiari-syndrome-secondary-to-essential-thrombocythaemia-complicated-by-acquired-von-willebrand-disease-and-mimicking-hepatic-malignancy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.100145","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}